SSRI Antidepressants Do Not Improve Depression After a Stroke
A study in JAMA Neurology finds that antidepressants do not reduce depression symptoms more than placebo in patients recovering from a stroke.
Overuse of Psychiatric Drugs is Worsening Public Mental Health, Doctor Argues
A new research article asserts that the overuse of psychiatric drugs may create neurobiological changes that hamper long-term mental health recovery.
New Review: Antidepressants Come with Minimal Benefits, Several Risks
A review of research on antidepressant efficacy finds that an unfavorable risk-to-benefit ratio.
Kenneth Kendler: “Implausible” That Psychiatric Diagnoses Even “Approximately True”
In JAMA Psychiatry, prominent psychiatrist Kenneth Kendler writes that psychiatric diagnoses are “working hypotheses, subject to change.”
Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
What Helps Long-Term Users of Benzodiazepines and Z-Drugs Discontinue?
Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.
For People “At Risk for Psychosis,” Antipsychotics Associated with Worse Outcomes
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.
Lithium No Better Than Placebo for Preventing Suicide Attempts
A trial in veterans who had survived a previous suicide attempt was stopped early because the drug was found to be no better than a placebo.
Antipsychotics Increase Risk of Dementia; New Research Illuminates Why
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.
Researchers Provide Guidance for Reducing and Stopping Psychiatric Drugs
New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.
When Psychology Speaks for You, Without You: Sunil Bhatia on Decolonizing Psychology
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Robin Williams On Antidepressant at Time of Suicide
Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...
Newborn Babies Go Through Antidepressant Withdrawal
A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.
Manufacturer of Tardive Dyskinesia (TD) Drugs Finds TD Emotionally Devastating
“Patients expressed feeling unaccepted by society or uncomfortable in their own skin… A few indicated that they would rather be dead than have tardive dyskinesia.”
Researchers Push to End Placebo Run-in Periods in Antidepressant Studies
Meta-analysis finds that the placebo run-in methodology reduces the placebo effect and finds antidepressants to be less useful.
Common Statistical Method Conflates Withdrawal with Relapse
Researchers argue that common study methods for psychiatric drugs may inadvertently minimize withdrawal effects and inflate drug efficacy.
Psychology is Not What You Think: An Interview with Critical Psychologist Ian Parker
MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.
Withdrawal Symptoms Cloud Findings of Antidepressant “Relapse” Trial
Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.
Tapered Antipsychotic Withdrawal Mitigates Risk of Psychotic Symptoms
Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.
Antipsychotics Linked to Increased Breast Cancer Risk
Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.
Suicide Rates Rise While Antidepressant Use Climbs
Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...
Sudden Antipsychotic Withdrawal—Not Low Dose—Leads to Relapse
A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.
New Research Questions Safety of Esketamine for Depression
An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.
Open Dialogue Approach Reduces Future Need for Mental Health Services
The Open Dialogue psychiatric treatment approach is associated with reduced utilization of mental and general health services for Danish youth.
Germanwings Pilot Saw Psychiatrist Three Times, Doubled Antidepressant Before Crash
The man who deliberately crashed a Germanwings commercial airliner with 150 passengers aboard was actively in psychiatric treatment at the time, reported the New...
